118 related articles for article (PubMed ID: 2180661)
1. Diabetes Control and Complications Trial (DCCT). Update. DCCT Research Group.
Diabetes Care; 1990 Apr; 13(4):427-33. PubMed ID: 2180661
[TBL] [Abstract][Full Text] [Related]
2. Implementation of treatment protocols in the Diabetes Control and Complications Trial.
Diabetes Care; 1995 Mar; 18(3):361-76. PubMed ID: 7555480
[TBL] [Abstract][Full Text] [Related]
3. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group.
Diabetes Care; 1987; 10(1):1-19. PubMed ID: 2882967
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.
Am J Med; 1991 Apr; 90(4):450-9. PubMed ID: 2012085
[TBL] [Abstract][Full Text] [Related]
5. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.
Nathan DM;
Diabetes Care; 2014; 37(1):9-16. PubMed ID: 24356592
[TBL] [Abstract][Full Text] [Related]
6. Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group.
Diabetes Care; 1988; 11(7):567-73. PubMed ID: 2904881
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
8. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).
; Nathan DM; Zinman B; Cleary PA; Backlund JY; Genuth S; Miller R; Orchard TJ
Arch Intern Med; 2009 Jul; 169(14):1307-16. PubMed ID: 19636033
[TBL] [Abstract][Full Text] [Related]
9. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group.
Diabetes; 1986 May; 35(5):530-45. PubMed ID: 2869996
[TBL] [Abstract][Full Text] [Related]
10. Intensive insulin therapy in insulin-dependent diabetes mellitus, the results of the diabetes control and complications trial.
Duron F
Biomed Pharmacother; 1995; 49(6):278-82. PubMed ID: 7579008
[TBL] [Abstract][Full Text] [Related]
11. Adverse events and their association with treatment regimens in the diabetes control and complications trial.
Diabetes Care; 1995 Nov; 18(11):1415-27. PubMed ID: 8722064
[TBL] [Abstract][Full Text] [Related]
12. The diabetes control and complications trial (DCCT): the trial coordinator perspective. Report by the DCCT Research Group.
Ahern JA; Kruger DF; Gatcomb PM; Petit WA; Tamborlane WV
Diabetes Educ; 1989; 15(3):236-41. PubMed ID: 2653757
[TBL] [Abstract][Full Text] [Related]
13. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions.
Gubitosi-Klug RA;
Diabetes Care; 2014; 37(1):44-9. PubMed ID: 24356597
[TBL] [Abstract][Full Text] [Related]
14. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.
; Orchard TJ; Nathan DM; Zinman B; Cleary P; Brillon D; Backlund JY; Lachin JM
JAMA; 2015 Jan; 313(1):45-53. PubMed ID: 25562265
[TBL] [Abstract][Full Text] [Related]
15. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
Diabetes; 1988 Apr; 37(4):476-81. PubMed ID: 2897940
[TBL] [Abstract][Full Text] [Related]
16. Evolution of the study coordinator role: the 28-year experience in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
Larkin ME; Lorenzi GM; Bayless M; Cleary PA; Barnie A; Golden E; Hitt S; Genuth S
Clin Trials; 2012 Aug; 9(4):418-25. PubMed ID: 22729476
[TBL] [Abstract][Full Text] [Related]
17. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
[TBL] [Abstract][Full Text] [Related]
18. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial.
Ann Intern Med; 1996 Feb; 124(4):379-88. PubMed ID: 8554246
[TBL] [Abstract][Full Text] [Related]
19. Diabetes--trials, tribulations and pay-off of tight control.
Cranston I; Evans M
J R Coll Physicians Lond; 1995; 29(5):431-4. PubMed ID: 8847690
[TBL] [Abstract][Full Text] [Related]
20. Intensive insulin regimens: evidence for benefit.
Bretzel RG
Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S8-13. PubMed ID: 15306832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
